SSR1 and central nervous system cancer: Investigation of the mechanisms upstream and downstream of circTLK1 revealed that circTLK1 mediated by PBX2 aggravates glioma progression by activating JAK/STAT signaling via the miR-452-5p/SSR1 axis.